Brock Reeve is CEO and Co-founder of Eos BioInnovation, an investment company focused on incubating and launching companies in the regenerative medicine field. From 2006-2022, Brock was the Executive Director of the Harvard Stem Cell Institute, a research center that grew to over 370 faculty spanning the schools of Harvard University and its affiliated hospitals and research institutions. Brock’s prior experience was in the commercial sector in both management consulting and operations for technology-based companies, with a focus on life sciences. Brock is on the Board of Directors of Axonis Therapeutics, HDAX Therapeutics, Regatta Bio, and Thrive Bioscience.